Clinical Study
Transcatheter Arterial Chemoembolization Is a Feasible Palliative Locoregional Therapy for Breast Cancer Liver Metastases
Table 1
Patient characteristics of breast cancer primary, liver metastasis and details of prior systemic therapy.
| Patient | Age | Treatment of Primary Ca | Axillary LN Status | Receptor Status | Extrahepatic metastasis before TACE | Interval between Diagnosis of Primary Breast Cancer and Liver Metastasis (in months) | Liver Metastasis Extent | Largest Liver Metastasis Size (in cm) | Previous Systemic Chemotherapy | Hormonal Treatment | Trastuzumab |
| 1 | 35 | mastectomy | positive | ER PR HER2/neu | L4 bone | 0 | multiple bilobar | | yes | no | yes |
| 2 | 44 | mastectomy | positive | ER PR HER2/neu | T12 bone | 95 | multiple bilobar | | yes | yes | yes |
| 3 | 52 | lumpectomy radiation, axillary LND | positive | ER PR HER2/neu | None | 14 | multiple bilobar | | yes | no | no |
| 4 | 34 | mastectomy | positive | ER PR HER2/neu | None | 24 | multiple bilobar | | yes | yes | no |
| 5 | 40 | lumpectomy radiation, axillary LND | positive | ER PR | multiple vertebral bones | 60 | multiple bilobar | | yes | yes | no |
| 6 | 60 | mastectomy | positive | ER PR | None | 0 | multiple bilobar | | yes | yes | no |
| 7 | 51 | axillary LND | positive | ER PR HER2/neu | None | 0 | multiple bilobar | | yes | no | yes |
| 8 | 29 | lumpectomy radiation | positive | ER PR HER2/neu | None | 16 | multiple bilobar | | yes | no | yes |
| 9 | 49 | lumpectomy radiation, axillary LND | positive | ER PR HER2/neu | multiple vertebral bones, Calcaneus | 93 | multiple bilobar | | yes | yes | no |
| 10 | 54 | mastectomy | positive | ER PR HER2/neu | C3, C4, C5 vertebral bones | 80 | right lobe | | yes | yes | no |
|
|